These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5949297)

  • 1. The immunobiology of cancer: tumor antigens and the responsiveness of the host.
    Hattler B; Amos B
    Monogr Surg Sci; 1966 Mar; 3(1):1-34. PubMed ID: 5949297
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunologic problems in cancer research].
    Sorkin E
    Praxis; 1969; 58(24):765-70. PubMed ID: 5819853
    [No Abstract]   [Full Text] [Related]  

  • 3. Host resistance to cancer.
    Goldstein G
    Aust N Z J Surg; 1967 Feb; 36(3):238-42. PubMed ID: 5227488
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tumor antigens and immune reactions against tumors].
    Trepel F
    Med Klin; 1971 Feb; 66(7):215-22. PubMed ID: 4928396
    [No Abstract]   [Full Text] [Related]  

  • 5. [Organ transplants and tumors].
    Minerva Med; 1971 Apr; 62(28):1479-83. PubMed ID: 4398103
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tumor immunology. Experience in man].
    Oettgen HF; Gallmeier WM
    Dtsch Med Wochenschr; 1968 Jun; 93(23):1157-61. PubMed ID: 4872860
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ontogenetic evolution of immune reactions].
    Hájek P
    Cesk Epidemiol Mikrobiol Imunol; 1971 May; 20(3):159-67. PubMed ID: 4398094
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumour specific antigens associated with chemically induced tumours.
    Baldwin RW
    Rev Eur Etud Clin Biol; 1970; 15(6):593-8. PubMed ID: 4319386
    [No Abstract]   [Full Text] [Related]  

  • 9. Augmentation of host immune responses to cancer: overcoming the barrier of tumor antigen-specific T-cell tolerance.
    Levitsky HI
    Cancer J; 2000 May; 6 Suppl 3():S281-90. PubMed ID: 10874499
    [No Abstract]   [Full Text] [Related]  

  • 10. [Possibilities of the immunotherapy of cancer].
    Tanaka S; Orita K
    Geka Chiryo; 1967 Nov; 17(5):522-8. PubMed ID: 4877443
    [No Abstract]   [Full Text] [Related]  

  • 11. [Application of the precipitation method in the studies of the drug antigenicity].
    Jakimowska-Dudzińska K
    Acta Pol Pharm; 1971; 28(2):207-12. PubMed ID: 5092583
    [No Abstract]   [Full Text] [Related]  

  • 12. A study of the immunologic responses in rabbits and C3H/HeJ mice from injection of live suspensions of strain MT-70 squamous cell carcinoma.
    Ziccardi JW
    J Am Osteopath Assoc; 1968 May; 67(9):1042-6. PubMed ID: 5185796
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunological aspects of tumor pathology].
    Piacentini G; Ferrari S
    Boll Ist Sieroter Milan; 1971; 50(3):199-208. PubMed ID: 5146577
    [No Abstract]   [Full Text] [Related]  

  • 14. [In vivo experiments for prevention of cancer and metastases with double- and triple fortification of the artificially stimulated unspecific immunologic defense. Supplementary "releasing" attacks against cancer cells within the concept of cancer multi-stage therapy].
    Ardenne M; Chaplain RA
    Dtsch Gesundheitsw; 1970 May; 25(19):861-6. PubMed ID: 5523781
    [No Abstract]   [Full Text] [Related]  

  • 15. [Transplantation immunity. Role of complement in transplantation immunity--"immune suppression"].
    Nelson RA
    Med Welt; 1966 Oct; 42():2259-61. PubMed ID: 5978475
    [No Abstract]   [Full Text] [Related]  

  • 16. [The hybrid effect].
    Burg C; Oth D
    Rev Fr Etud Clin Biol; 1967 Oct; 12(8):761-6. PubMed ID: 6076485
    [No Abstract]   [Full Text] [Related]  

  • 17. Partially circumventing peripheral tolerance for oncogene-specific prostate cancer immunotherapy.
    Neeley YC; Arredouani MS; Hollenbeck B; Eng MH; Rubin MA; Sanda MG
    Prostate; 2008 May; 68(7):715-27. PubMed ID: 18302222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased susceptibility to tumor cell immunosuppressive effect in tumor-bearing mice.
    Ting CC; Rodrigues D
    J Natl Cancer Inst; 1980 Jul; 65(1):205-9. PubMed ID: 6967124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunologic factors relating to tumor growth and dissemination].
    Alexander P
    Maroc Med; 1972 Oct; 52(561):565-70. PubMed ID: 4667466
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumor immunosuppressive environment: effects on tumor-specific and nontumor antigen immune responses.
    de Souza AP; Bonorino C
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1317-32. PubMed ID: 19761435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.